Empiric use of anticoagulant and fibrinolytic agents in surgical therapy
Laufman, H.
American Surgeon 40(1): 15-21
1974
ISSN/ISBN: 0003-1348 PMID: 4808618 Document Number: 77694
Document emailed within 1 workday
Related Documents
Engelken, H.J.; Martin, M. 1974: Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease Die Medizinische Welt 25(25): 1122-1124Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472
Franzosi, M.G. 2001: Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(9): 1034-1036
Blinder, D.; Martinowitz, U.; Ardekian, L.; Peleg, M.; Taicher, S. 1996: Oral surgical procedures during anticoagulant therapy Harefuah 130(10): 681
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Oknińska, A.; Ostojska, J.; Galczak, W.; Grygalewicz, J.; Antoszewska, A. 1978: Fibrinolytic and anticoagulant treatment in selected cases of glomerulonephritis in children Pediatria Polska 53(4): 513-522
Francis, R.B.; Neely, S. 1989: Effect of the lupus anticoagulant on endothelial fibrinolytic activity in vitro Thrombosis and Haemostasis 61(2): 314-317
Tinker, J.H.; Tarhan, S. 1978: Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations JAMA 239(8): 738-739
Rich, K.; Safranek, S.; Malaty, W. 2005: Clinical inquiries. Is therapy based on endoscopy results better than empiric therapy for dyspepsia? Journal of Family Practice 54(8): 725-726
Inciardi, J.F. 1994: Empiric therapy for febrile neutropenia Annals of Internal Medicine 121(8): 623-624
Sloan, F.A.; Perrin, J.M.; Valvona, J. 1986: In-hospital mortality of surgical patients: is there an empiric basis for standard setting? Surgery 99(4): 446-454
Wojda, B.; Ahkee, S.; Uyamadu, N.; Jouja, K.; Ramirez, J.A. 1997: Tuberculosis in Kentucky: current recommendations for empiric therapy Journal of the Kentucky Medical Association 95(3): 98-101
Rawlings, D.; Ferriero, D.M.; Messing, R.O. 1989: Early CT reevaluation after empiric praziquantel therapy in neurocysticercosis Neurology 39(5): 739-741
Loewenthal, M.R. 1998: Management and prevention of meningococcal disease. Use benzylpenicillin for empiric therapy Medical Journal of Australia 168(4): 195; Author Reply 196-7
Ishikawa, K. 2003: Anticoagulant, antiplatelet agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 4): 647-653
Lugannani, C.; Strickland, C. 1999: Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients? Journal of Family Practice 48(12): 998
De Rosa, L.; Montuoro, A.; De Blasio, A.; Della Seta, R.; Pacilli, L.; Pescador, L.; Petti, N.; De Laurenzi, A. 1990: Empiric antibiotic and antifungal therapy for granulocytopenic patients with acute leukemia Recenti Progressi in Medicina 81(1): 37-40
Vairel, E.G.; Choay, J.; Toulemonde, F. 1983: Current data on fibrinolytic agents used in clinical medicine Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 24(11): 555-558
Arisz, L.; Tegzess, A.M.; Jordans, J.G.; van der Hem, G.K. 1970: Fibrinolytic agents in the management of thrombosed arteriovenous shunt Nederlands Tijdschrift Voor Geneeskunde 114(36): 1484-1490
Klastersky, J.; Debusscher, L.; Weerts-Ruhl, D.; Prevost, J.M. 1977: Carbenicillin, cefazolin, and amikacin as an empiric therapy for febrile granulocytopenic cancer patients Cancer Treatment Reports 61(8): 1433-1439